Radiocontrast Media: Adverse Reactions and Side Effects

Dear Colleagues,

Radiocontrast media (RCM) are widely used around the world and generally well tolerated. However, adverse reaction (both immediate and delayed) and side effects are not uncommon.
In recent years, new evidence has emerged regarding pathogenetic mechanisms, risk factors, prevention and management of reactions and adverse events to RCM. It should also be emphasized that the most recent contrast media have hugely different characteristics from older ones (e.g., iodinated ionic and hyper-osmolar RCMs), and knowledge about the use of the latter cannot be applied to the newer compounds.

The topic of adverse reactions to RCM has a double interest in diagnostics: it is of interest to radiologists, who use RCM on a daily basis and are faced with adverse reactions themselves, and also to prescribers, because a correct management of the risk of adverse reaction starts from the moment of the patient evaluation and the prescription of the investigation that includes the use of RCM. In summary, the problem of adverse reactions to RCM affects anyone who prescribes or performs an investigation that involves RCM use.

The objective of this Special Issue would be to provide the clinician with the most current evidence on adverse reactions to RCMs—both of the immune-mediated and non-immune-mediated types—with a particular focus on diagnosis and risk stratification.

Dr. Filippo Fassio
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.